Ftse Mib
38.622,84
-1,53%
DAX
22.550,89
-1,08%
S&P 500
5.861,57
-1,59%
NASDAQ
18.544,42
-2,78%
Bitcoin
79.682,24
-5,93%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sigilon Therapeutics Inc (SGTX) Sigilon Therapeutics Inc (SGTX) Notizie

SGTX

Sigilon Therapeutics (SGTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SGTX
DataOraFonteTitoloSimboloCompagnia
21/08/202314:22Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:SGTXSigilon Therapeutics Inc
16/08/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SGTXSigilon Therapeutics Inc
14/08/202313:25PR Newswire (US)Lilly Completes Acquisition of Sigilon TherapeuticsNASDAQ:SGTXSigilon Therapeutics Inc
11/08/202322:28Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:SGTXSigilon Therapeutics Inc
11/08/202322:20Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SGTXSigilon Therapeutics Inc
11/08/202322:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGTXSigilon Therapeutics Inc
11/08/202322:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGTXSigilon Therapeutics Inc
10/08/202314:31Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:SGTXSigilon Therapeutics Inc
07/08/202314:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SGTXSigilon Therapeutics Inc
13/07/202314:18Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:SGTXSigilon Therapeutics Inc
29/06/202313:35Dow Jones NewsEli Lilly to Acquire Sigilon TherapeuticsNASDAQ:SGTXSigilon Therapeutics Inc
29/06/202313:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SGTXSigilon Therapeutics Inc
29/06/202312:57Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:SGTXSigilon Therapeutics Inc
29/06/202312:45PR Newswire (US)Lilly to Acquire Sigilon TherapeuticsNASDAQ:SGTXSigilon Therapeutics Inc
22/05/202322:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SGTXSigilon Therapeutics Inc
22/05/202313:30GlobeNewswire Inc.Sigilon Announces Reverse Stock Split of Common StockNASDAQ:SGTXSigilon Therapeutics Inc
09/05/202314:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SGTXSigilon Therapeutics Inc
09/05/202313:30GlobeNewswire Inc.Sigilon Therapeutics Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:SGTXSigilon Therapeutics Inc
02/05/202315:00PR Newswire (US)Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D., as Board Director and Chris Ehrlich as Senior AdvisorNASDAQ:SGTXSigilon Therapeutics Inc
18/04/202313:00GlobeNewswire Inc.Sigilon Therapeutics to Present at the Needham Virtual Healthcare ConferenceNASDAQ:SGTXSigilon Therapeutics Inc
06/04/202313:07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SGTXSigilon Therapeutics Inc
06/04/202313:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SGTXSigilon Therapeutics Inc
23/03/202322:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:SGTXSigilon Therapeutics Inc
14/03/202321:26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SGTXSigilon Therapeutics Inc
14/03/202321:15GlobeNewswire Inc.Sigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsNASDAQ:SGTXSigilon Therapeutics Inc
01/03/202322:37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SGTXSigilon Therapeutics Inc
10/11/202213:30GlobeNewswire Inc.Sigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business HighlightsNASDAQ:SGTXSigilon Therapeutics Inc
04/08/202222:30GlobeNewswire Inc.Sigilon Therapeutics Reports Second Quarter 2022 Financial Results and Business HighlightsNASDAQ:SGTXSigilon Therapeutics Inc
08/07/202222:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SGTXSigilon Therapeutics Inc
12/05/202222:05GlobeNewswire Inc.Sigilon Therapeutics Reports First Quarter 2022 Financial Results And Business HighlightsNASDAQ:SGTXSigilon Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SGTX

La tua Cronologia

NYSE
BLDR
Builders FirstSource
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci